Cargando…

The cost of vaccination throughout life: A western European overview

Despite the interest of policy makers, the actual investment in vaccination is poorly documented. Our study assessed the costs of vaccination throughout life for a fully immunized Western European citizen. National vaccination calendars for England, France, Germany, Italy, Portugal, Spain and Sweden...

Descripción completa

Detalles Bibliográficos
Autores principales: Ethgen, Olivier, Cornier, Murielle, Chriv, Emilie, Baron-Papillon, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994732/
https://www.ncbi.nlm.nih.gov/pubmed/27050111
http://dx.doi.org/10.1080/21645515.2016.1154649
_version_ 1782449372457336832
author Ethgen, Olivier
Cornier, Murielle
Chriv, Emilie
Baron-Papillon, Florence
author_facet Ethgen, Olivier
Cornier, Murielle
Chriv, Emilie
Baron-Papillon, Florence
author_sort Ethgen, Olivier
collection PubMed
description Despite the interest of policy makers, the actual investment in vaccination is poorly documented. Our study assessed the costs of vaccination throughout life for a fully immunized Western European citizen. National vaccination calendars for England, France, Germany, Italy, Portugal, Spain and Sweden were retrieved. We differentiated men from women and healthy individuals from those suffering from underlying conditions who require specific additional vaccinations. Vaccine costs and administration fees were retrieved from official national source and calculated from the national healthcare perspective. Vaccinating an individual against up to 17 diseases throughout his entire life and in full compliance with national vaccination calendars cost between €328 and €2,352 (vaccines costs only) and between €443 and €3,395 (administration costs included), the lowest range corresponds to a healthy man in Sweden and the highest to a woman with underlying conditions in England. Vaccination costs varied among countries due to heterogeneous national vaccination calendars and organization. In all countries, adults (18–64 y) and elderly (≥65 y) accounted for the lowest vaccines costs compared with infants (0–24 m) and children/adolescents (2–17 y). In comparison, other mass secondary preventive therapies may be at least 3 times more costly. Vaccination requires a relatively low level of investment per individual. Our estimates should be considered to be the maximum potential costs due to our 100% compliance assumption. Increasing coverage rates would bring additional public health benefits for a relatively low incremental cost. A life-course approach of vaccination should also be encouraged because some missed opportunities remain in senior vaccinations.
format Online
Article
Text
id pubmed-4994732
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-49947322016-08-30 The cost of vaccination throughout life: A western European overview Ethgen, Olivier Cornier, Murielle Chriv, Emilie Baron-Papillon, Florence Hum Vaccin Immunother Research Papers Despite the interest of policy makers, the actual investment in vaccination is poorly documented. Our study assessed the costs of vaccination throughout life for a fully immunized Western European citizen. National vaccination calendars for England, France, Germany, Italy, Portugal, Spain and Sweden were retrieved. We differentiated men from women and healthy individuals from those suffering from underlying conditions who require specific additional vaccinations. Vaccine costs and administration fees were retrieved from official national source and calculated from the national healthcare perspective. Vaccinating an individual against up to 17 diseases throughout his entire life and in full compliance with national vaccination calendars cost between €328 and €2,352 (vaccines costs only) and between €443 and €3,395 (administration costs included), the lowest range corresponds to a healthy man in Sweden and the highest to a woman with underlying conditions in England. Vaccination costs varied among countries due to heterogeneous national vaccination calendars and organization. In all countries, adults (18–64 y) and elderly (≥65 y) accounted for the lowest vaccines costs compared with infants (0–24 m) and children/adolescents (2–17 y). In comparison, other mass secondary preventive therapies may be at least 3 times more costly. Vaccination requires a relatively low level of investment per individual. Our estimates should be considered to be the maximum potential costs due to our 100% compliance assumption. Increasing coverage rates would bring additional public health benefits for a relatively low incremental cost. A life-course approach of vaccination should also be encouraged because some missed opportunities remain in senior vaccinations. Taylor & Francis 2016-04-06 /pmc/articles/PMC4994732/ /pubmed/27050111 http://dx.doi.org/10.1080/21645515.2016.1154649 Text en © 2015 The Author(s). Published with license by Taylor & Francis http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Research Papers
Ethgen, Olivier
Cornier, Murielle
Chriv, Emilie
Baron-Papillon, Florence
The cost of vaccination throughout life: A western European overview
title The cost of vaccination throughout life: A western European overview
title_full The cost of vaccination throughout life: A western European overview
title_fullStr The cost of vaccination throughout life: A western European overview
title_full_unstemmed The cost of vaccination throughout life: A western European overview
title_short The cost of vaccination throughout life: A western European overview
title_sort cost of vaccination throughout life: a western european overview
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994732/
https://www.ncbi.nlm.nih.gov/pubmed/27050111
http://dx.doi.org/10.1080/21645515.2016.1154649
work_keys_str_mv AT ethgenolivier thecostofvaccinationthroughoutlifeawesterneuropeanoverview
AT corniermurielle thecostofvaccinationthroughoutlifeawesterneuropeanoverview
AT chrivemilie thecostofvaccinationthroughoutlifeawesterneuropeanoverview
AT baronpapillonflorence thecostofvaccinationthroughoutlifeawesterneuropeanoverview
AT ethgenolivier costofvaccinationthroughoutlifeawesterneuropeanoverview
AT corniermurielle costofvaccinationthroughoutlifeawesterneuropeanoverview
AT chrivemilie costofvaccinationthroughoutlifeawesterneuropeanoverview
AT baronpapillonflorence costofvaccinationthroughoutlifeawesterneuropeanoverview